215 results on '"Resection Cavity"'
Search Results
2. Automated segmentation of epilepsy surgical resection cavities: Comparison of four methods to manual segmentation
- Author
-
Merran R. Courtney, Benjamin Sinclair, Andrew Neal, John-Paul Nicolo, Patrick Kwan, Meng Law, Terence J. O'Brien, and Lucy Vivash
- Subjects
Epilepsy ,Automated segmentation ,MRI ,Neurosurgery ,Resection cavity ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Accurate resection cavity segmentation on MRI is important for neuroimaging research involving epilepsy surgical outcomes. Manual segmentation, the gold standard, is highly labour intensive. Automated pipelines are an efficient potential solution; however, most have been developed for use following temporal epilepsy surgery. Our aim was to compare the accuracy of four automated segmentation pipelines following surgical resection in a mixed cohort of subjects following temporal or extra temporal epilepsy surgery. We identified 4 open-source automated segmentation pipelines. Epic-CHOP and ResectVol utilise SPM-12 within MATLAB, while Resseg and Deep Resection utilise 3D U-net convolutional neural networks. We manually segmented the resection cavity of 50 consecutive subjects who underwent epilepsy surgery (30 temporal, 20 extratemporal). We calculated Dice similarity coefficient (DSC) for each algorithm compared to the manual segmentation. No algorithm identified all resection cavities. ResectVol (n = 44, 88 %) and Epic-CHOP (n = 42, 84 %) were able to detect more resection cavities than Resseg (n = 22, 44 %, P < 0.001) and Deep Resection (n = 23, 46 %, P < 0.001). The SPM-based pipelines (Epic-CHOP and ResectVol) performed better than the deep learning-based pipelines in the overall and extratemporal surgery cohorts. In the temporal cohort, the SPM-based pipelines had higher detection rates, however there was no difference in the accuracy between methods. These pipelines could be applied to machine learning studies of outcome prediction to improve efficiency in pre-processing data, however human quality control is still required.
- Published
- 2024
- Full Text
- View/download PDF
3. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors
- Author
-
L. Hahnemann, A. Krämer, C. Fink, C. Jungk, M. Thomas, P. Christopoulos, J.W. Lischalk, J. Meis, J. Hörner-Rieber, T. Eichkorn, M. Deng, K. Lang, A. Paul, E. Meixner, F. Weykamp, J. Debus, and L. König
- Subjects
Fractionated stereotactic radiotherapy ,Brain metastases ,Resection cavity ,Radiation-induced contrast enhancements ,Immunotherapy ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background and Purpose: After surgical resection of brain metastases (BM), radiotherapy (RT) is indicated. Postoperative stereotactic radiosurgery (SRS) reduces the risk of local progression and neurocognitive decline compared to whole brain radiotherapy (WBRT). Aside from the optimal dose and fractionation, little is known about the combination of systemic therapy and postoperative fractionated stereotactic radiotherapy (fSRT), especially regarding tumour control and toxicity. Methods: In this study, 105 patients receiving postoperative fSRT with 35 Gy in 7 fractions performed with Cyberknife were retrospectively reviewed. Overall survival (OS), local control (LC) and total intracranial brain control (TIBC) were analysed via Kaplan-Meier method. Cox proportional hazards models were used to identify prognostic factors. Results: Median follow-up was 20.8 months. One-year TIBC was 61.6% and one-year LC was 98.6%. Median OS was 28.7 (95%-CI: 16.9–40.5) months. In total, local progression (median time not reached) occurred in 2.0% and in 20.4% radiation-induced contrast enhancements (RICE) of the cavity (after median of 14.3 months) were diagnosed. Absence of extracranial metastases was identified as an independent prognostic factor for superior OS (p =
- Published
- 2024
- Full Text
- View/download PDF
4. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities.
- Author
-
Molina-Peña, Rodolfo, Ferreira, Natália Helen, Roy, Charlotte, Roncali, Loris, Najberg, Mathie, Avril, Sylvie, Zarur, Mariana, Bourgeois, William, Ferreirós, Alba, Lucchi, Chiara, Cavallieri, Francesco, Hindré, François, Tosi, Giovani, Biagini, Giuseppe, Valzania, Franco, Berger, François, Abal, Miguel, Rousseau, Audrey, Boury, Frank, and Alvarez-Lorenzo, Carmen
- Subjects
SILK fibroin ,HYALURONIC acid ,TUMOR surgery ,AEROGELS ,GLIOBLASTOMA multiforme ,ECOSYSTEMS - Abstract
In view of inevitable recurrences despite resection, glioblastoma (GB) is still an unmet clinical need. Dealing with the stromal-cell derived factor 1-alpha (SDF-1α)/CXCR4 axis as a hallmark of infiltrative GB tumors and with the resection cavity situation, the present study described the effects and relevance of a new engineered micro-nanostructured SF-HA-Hep aerogel sponges, made of silk fibroin (SF), hyaluronic acid (HA) and heparin (Hep) and loaded with SDF-1α, to interfere with the GB ecosystem and residual GB cells, attracting and confining them in a controlled area before elimination. 70 µm-pore sponges were designed as an implantable scaffold to trap GB cells. They presented shape memory and fit brain cavities. Histological results after implantation in brain immunocompetent Fischer rats revealed that SF-HA-Hep sponges are well tolerated for more than 3 months while moderately and reversibly colonized by immuno-inflammatory cells. The use of human U87MG GB cells overexpressing the CXCR4 receptor (U87MG-CXCR4+) and responding to SDF-1α allowed demonstrating directional GB cell attraction and colonization of the device in vitro and in vivo in orthotopic resection cavities in Nude rats. Not modifying global survival, aerogel sponge implantation strongly shaped U87MG-CXCR4+ tumors in cavities in contrast to random infiltrative growth in controls. Overall, those results support the interest of SF-HA-Hep sponges as modifiers of the GB ecosystem dynamics acting as "cell meeting rooms" and biocompatible niches whose properties deserve to be considered toward the development of new clinical procedures. Brain tumor glioblastoma (GB) is one of the worst unmet clinical needs. To prevent the relapse in the resection cavity situation, new implantable biopolymer aerogel sponges loaded with a chemoattractant molecule were designed and preclinically tested as a prototype targeting the interaction between the initial tumor location and its attraction by the peritumoral environment. While not modifying global survival, biocompatible SDF1-loaded hyaluronic acid and silk fibroin sponges induce directional GB cell attraction and colonization in vitro and in rats in vivo. Interestingly, they strongly shaped GB tumors in contrast to random infiltrative growth in controls. These results provide original findings on application of exogenous engineered niches that shape tumors and serve as cell meeting rooms for further clinical developments. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Anatomical changes in resection cavity during brain radiotherapy.
- Author
-
Willems, Yves C. P., Vaassen, Femke, Zegers, Catharina M. L., Postma, Alida A., Jaspers, Jaap, Romero, Alejandra Méndez, Unipan, Mirko, Swinnen, Ans, Anten, Monique, Teernstra, Onno, Compter, Inge, van Elmpt, Wouter, and Eekers, Daniëlle B. P.
- Abstract
Background and purpose: Brain tumors are in general treated with a maximal safe resection followed by radiotherapy of remaining tumor including the resection cavity (RC) and chemotherapy. Anatomical changes of the RC during radiotherapy can have impact on the coverage of the target volume. The aim of the current study was to quantify the potential changes of the RC and to identify risk factors for RC changes. Materials and methods: Sixteen patients treated with pencil beam scanning proton therapy between October 2019 and April 2020 were retrospectively analyzed. The RC was delineated on pre-treatment computed tomography (CT) and magnetic resonance imaging, and weekly CT-scans during treatment. Isotropic expansions were applied to the pre-treatment RC (1–5 mm). The percentage of volume of the RC during treatment within the expanded pre-treatment volumes was quantified. Potential risk factors (volume of RC, time interval surgery-radiotherapy and relationship of RC to the ventricles) were evaluated using Spearman's rank correlation coefficient. Results: The average variation in relative RC volume during treatment was 26.1% (SD 34.6%). An expansion of 4 mm was required to cover > 95% of the RC volume in > 90% of patients. There was a significant relationship between the absolute volume of the pre-treatment RC and the volume changes during treatment (Spearman's ρ = − 0.644; p = 0.007). Conclusion: RCs are dynamic after surgery. Potentially, an additional margin in brain cancer patients with an RC should be considered, to avoid insufficient target coverage. Future research on local recurrence patterns is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
- Author
-
Maria Waltenberger, Denise Bernhardt, Christian Diehl, Jens Gempt, Bernhard Meyer, Christoph Straube, Benedikt Wiestler, Jan J. Wilkens, Claus Zimmer, and Stephanie E. Combs
- Subjects
Brain metastases ,Resection cavity ,Local control ,Stereotactic radiotherapy ,Radiosurgery ,Clinical trial ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The brain is a common site for cancer metastases. In case of large and/or symptomatic brain metastases, neurosurgical resection is performed. Adjuvant radiotherapy is a standard procedure to minimize the risk of local recurrence and is increasingly performed as local stereotactic radiotherapy to the resection cavity. Both hypofractionated stereotactic radiotherapy (HFSRT) and single fraction stereotactic radiosurgery (SRS) can be applied in this case. Although adjuvant stereotactic radiotherapy to the resection cavity is widely used in clinical routine and recommended in international guidelines, the optimal fractionation scheme still remains unclear. The SATURNUS trial prospectively compares adjuvant HFSRT with SRS and seeks to detect the superiority of HFSRT over SRS in terms of local tumor control. Methods In this single center two-armed randomized phase III trial, adjuvant radiotherapy to the resection cavity of brain metastases with HFSRT (6 – 7 × 5 Gy prescribed to the surrounding isodose) is compared to SRS (1 × 12–20 Gy prescribed to the surrounding isodose). Patients are randomized 1:1 into the two different treatment arms. The primary endpoint of the trial is local control at the resected site at 12 months. The trial is based on the hypothesis that HFSRT is superior to SRS in terms of local tumor control. Discussion Although adjuvant stereotactic radiotherapy after resection of brain metastases is considered standard of care treatment, there is a need for further prospective research to determine the optimal fractionation scheme. To the best of our knowledge, the SATURNUS study is the only randomized phase III study comparing different regimes of postoperative stereotactic radiotherapy to the resection cavity adequately powered to detect the superiority of HFSRT regarding local control. Trial registration The study was retrospectively registered with ClinicalTrials.gov, number NCT05160818, on December 16, 2021. The trial registry record is available on https://clinicaltrials.gov/study/NCT05160818 . The presented protocol refers to version V1.3 from March 21, 2021.
- Published
- 2023
- Full Text
- View/download PDF
7. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
- Author
-
Waltenberger, Maria, Bernhardt, Denise, Diehl, Christian, Gempt, Jens, Meyer, Bernhard, Straube, Christoph, Wiestler, Benedikt, Wilkens, Jan J., Zimmer, Claus, and Combs, Stephanie E.
- Subjects
- *
CLINICAL trials , *STEREOTACTIC radiotherapy , *STEREOTACTIC radiosurgery , *SURGICAL excision , *STEREOTAXIC techniques , *RESEARCH protocols , *METASTASIS - Abstract
Background: The brain is a common site for cancer metastases. In case of large and/or symptomatic brain metastases, neurosurgical resection is performed. Adjuvant radiotherapy is a standard procedure to minimize the risk of local recurrence and is increasingly performed as local stereotactic radiotherapy to the resection cavity. Both hypofractionated stereotactic radiotherapy (HFSRT) and single fraction stereotactic radiosurgery (SRS) can be applied in this case. Although adjuvant stereotactic radiotherapy to the resection cavity is widely used in clinical routine and recommended in international guidelines, the optimal fractionation scheme still remains unclear. The SATURNUS trial prospectively compares adjuvant HFSRT with SRS and seeks to detect the superiority of HFSRT over SRS in terms of local tumor control. Methods: In this single center two-armed randomized phase III trial, adjuvant radiotherapy to the resection cavity of brain metastases with HFSRT (6 – 7 × 5 Gy prescribed to the surrounding isodose) is compared to SRS (1 × 12–20 Gy prescribed to the surrounding isodose). Patients are randomized 1:1 into the two different treatment arms. The primary endpoint of the trial is local control at the resected site at 12 months. The trial is based on the hypothesis that HFSRT is superior to SRS in terms of local tumor control. Discussion: Although adjuvant stereotactic radiotherapy after resection of brain metastases is considered standard of care treatment, there is a need for further prospective research to determine the optimal fractionation scheme. To the best of our knowledge, the SATURNUS study is the only randomized phase III study comparing different regimes of postoperative stereotactic radiotherapy to the resection cavity adequately powered to detect the superiority of HFSRT regarding local control. Trial registration: The study was retrospectively registered with ClinicalTrials.gov, number NCT05160818, on December 16, 2021. The trial registry record is available on https://clinicaltrials.gov/study/NCT05160818. The presented protocol refers to version V1.3 from March 21, 2021. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI–Linear Accelerator.
- Author
-
Guevara, Beatriz, Cullison, Kaylie, Maziero, Danilo, Azzam, Gregory A., De La Fuente, Macarena I., Brown, Karen, Valderrama, Alessandro, Meshman, Jessica, Breto, Adrian, Ford, John Chetley, and Mellon, Eric A.
- Subjects
- *
GLIOMAS , *MAGNETIC resonance imaging , *SIMULATION methods in education , *DOSE-response relationship (Radiation) , *TEMOZOLOMIDE , *DESCRIPTIVE statistics , *RESEARCH funding - Abstract
Simple Summary: Cognitive function after brain radiation therapy (RT) is correlated with radiation doses to the normal brain and hippocampi. During the RT of glioblastoma, daily magnetic resonance imaging (MRI) by combination MRI–linear accelerator (MRI–Linac) systems has demonstrated significant anatomic changes due to evolving post-surgical cavity shrinkage. Therefore, this study aimed to investigate if adaptive planning to the shrinking target could reduce the normal brain RT dose with the goal of improving post-RT function. We evaluated a cohort of 10 glioblastoma patients previously treated on a 0.35T MRI–Linac with a prescription of 60 Gy delivered in 30 fractions over six weeks without adaptation ("static plan") with concurrent temozolomide. Six weekly plans were created per patient. Reductions in radiation dose to the hippocampi (maximum and mean) and brain (mean) were observed for weekly adaptive plans. Weekly adaptive re-planning has the potential to spare the brain and hippocampi from high-dose radiation, likely reducing the neurocognitive side effects of RT. During radiation therapy (RT) of glioblastoma, daily MRI with combination MRI–linear accelerator (MRI–Linac) systems has demonstrated significant anatomic changes, including evolving post-surgical cavity shrinkage. Cognitive function RT for brain tumors is correlated with radiation doses to healthy brain structures, especially the hippocampi. Therefore, this study investigates whether adaptive planning to the shrinking target could reduce normal brain RT dose with the goal of improving post-RT function. We evaluated 10 glioblastoma patients previously treated on a 0.35T MRI–Linac with a prescription of 60 Gy delivered in 30 fractions over six weeks without adaptation ("static plan") with concurrent temozolomide chemotherapy. Six weekly plans were created per patient. Reductions in the radiation dose to uninvolved hippocampi (maximum and mean) and brain (mean) were observed for weekly adaptive plans. The dose (Gy) to the hippocampi for static vs. weekly adaptive plans were, respectively: max 21 ± 13.7 vs. 15.2 ± 8.2 (p = 0.003) and mean 12.5 ± 6.7 vs. 8.4 ± 4.0 (p = 0.036). The mean brain dose was 20.6 ± 6.0 for static planning vs. 18.7 ± 6.8 for weekly adaptive planning (p = 0.005). Weekly adaptive re-planning has the potential to spare the brain and hippocampi from high-dose radiation, possibly reducing the neurocognitive side effects of RT for eligible patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Automated segmentation of epilepsy surgical resection cavities: Comparison of four methods to manual segmentation.
- Author
-
Courtney, Merran R., Sinclair, Benjamin, Neal, Andrew, Nicolo, John-Paul, Kwan, Patrick, Law, Meng, O'Brien, Terence J., and Vivash, Lucy
- Subjects
- *
TEMPORAL lobectomy , *SURGICAL excision , *EPILEPSY surgery , *CONVOLUTIONAL neural networks , *EPILEPSY , *QUALITY control - Abstract
• The SPM-based automated epilepsy surgery segmentation tools performed better than the deep learning-based tools on our mixed cohort of subjects who had either temporal or extratemporal epilepsy surgery. • All four tools performed similarly well on the temporal epilepsy subgroup. • The accuracy of each model improved as the size of the resection cavity increased. • Quality control is an important step when implementing the tools, as no algorithm was able to segment every epilepsy surgery resection cavity. Accurate resection cavity segmentation on MRI is important for neuroimaging research involving epilepsy surgical outcomes. Manual segmentation, the gold standard, is highly labour intensive. Automated pipelines are an efficient potential solution; however, most have been developed for use following temporal epilepsy surgery. Our aim was to compare the accuracy of four automated segmentation pipelines following surgical resection in a mixed cohort of subjects following temporal or extra temporal epilepsy surgery. We identified 4 open-source automated segmentation pipelines. Epic-CHOP and ResectVol utilise SPM-12 within MATLAB, while Resseg and Deep Resection utilise 3D U-net convolutional neural networks. We manually segmented the resection cavity of 50 consecutive subjects who underwent epilepsy surgery (30 temporal, 20 extratemporal). We calculated Dice similarity coefficient (DSC) for each algorithm compared to the manual segmentation. No algorithm identified all resection cavities. ResectVol (n = 44, 88 %) and Epic-CHOP (n = 42, 84 %) were able to detect more resection cavities than Resseg (n = 22, 44 %, P < 0.001) and Deep Resection (n = 23, 46 %, P < 0.001). The SPM-based pipelines (Epic-CHOP and ResectVol) performed better than the deep learning-based pipelines in the overall and extratemporal surgery cohorts. In the temporal cohort, the SPM-based pipelines had higher detection rates, however there was no difference in the accuracy between methods. These pipelines could be applied to machine learning studies of outcome prediction to improve efficiency in pre-processing data, however human quality control is still required. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant
- Author
-
McCutcheon, Ian E., Steiger, Hans-Jakob, Series Editor, Chernov, Mikhail F., editor, Hayashi, Motohiro, editor, Chen, Clark C., editor, and McCutcheon, Ian E., editor
- Published
- 2021
- Full Text
- View/download PDF
11. Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs-131) for Intra-Operative Brain Implants.
- Author
-
Han, Dae Y, Ma, Lijun, Braunstein, Steve, Raleigh, David, Sneed, Patricia K, and McDermott, Michael
- Subjects
brachytherapy ,brain metastasis ,cs-131 ,i-125 ,ldr ,resection cavity ,Medical and Health Sciences - Abstract
Background and Objectives Intra-parenchymal brain surgical resection cavities usually contract in volume following low dose rate (LDR) brachytherapy implants. In this study, we systematically modeled and assessed dose variability resulting from such changes for I-125 versus Cs-131 radioactive sources. Methods Resection cavity contraction was modeled based on 95 consecutive patient cases, using surveillance magnetic resonance (MR) images. The model was derived for single point source geometry and then fully simulated in 3D where I-125 or Cs-131 seeds were placed on the surface of an ellipsoidal resection cavity. Dose distribution estimated via TG-43 calculations and biological effective dose (BED) calculations were compared for both I-125 and Cs-131, accounting for resection cavity contractions. Results Resection cavity volumes were found to contract with an effective half-life of approximately 3.4 months (time to reach 50% of maximum volume contraction). As a result, significant differences in dose distributions were noted between I-125 and Cs-131 radioactive sources. For example, when comparing with static volume, assuming no contraction effect, I-125 exhibited a 31.8% and 30.5% increase in D90 and D10 values (i.e., the minimal dose to 90% and 10% of the volume respectively) in the peripheral target areas over the follow-up period of 20.5 months. In contrast, Cs-131 seeds only exhibited a 1.44% and 0.64% increase in D90 and D10 values respectively. Such discrepancy is likewise similar for BED calculations. Conclusion Resection cavity contractions affects Cs-131 dose distribution significantly less than that of I-125 for permanent brain implants. Care must be taken to account for cavity contractions when prescribing accumulative doses of a radioactive source in performing the brain implant procedures.
- Published
- 2018
12. CyberKnife Neuroradiosurgery for Large Brain Metastases and Tumor Bed
- Author
-
Ruge, Maximilian I., Conti, Alfredo, editor, Romanelli, Pantaleo, editor, Pantelis, Evangelos, editor, Soltys, Scott G., editor, Cho, Young Hyun, editor, and Lim, Michael, editor
- Published
- 2020
- Full Text
- View/download PDF
13. Applications of Stereotactic Radiosurgery for Brain Metastases
- Author
-
Save, Akshay V., Higgins, Dominique M. O., Mayeda, Mark D., Wang, Tony J. C., Ramakrishna, Rohan, editor, Magge, Rajiv S., editor, Baaj, Ali A., editor, and Knisely, Jonathan P.S., editor
- Published
- 2020
- Full Text
- View/download PDF
14. Stereotactic Radiosurgery: Indications and Outcomes in Central Nervous System and Skull Base Metastases
- Author
-
Ruiz-Garcia, Henry Jeison, Trifiletti, Daniel M., Sheehan, Jason P., Ramakrishna, Rohan, editor, Magge, Rajiv S., editor, Baaj, Ali A., editor, and Knisely, Jonathan P.S., editor
- Published
- 2020
- Full Text
- View/download PDF
15. Current status and recent advances in resection cavity irradiation of brain metastases
- Author
-
Giuseppe Minniti, Maximilian Niyazi, Nicolaus Andratschke, Matthias Guckenberger, Joshua D. Palmer, Helen A. Shih, Simon S. Lo, Scott Soltys, Ivana Russo, Paul D. Brown, and Claus Belka
- Subjects
Stereotactic radiosurgery ,Hypofractionated stereotactic radiotherapy ,Resection cavity ,Brain metastases ,Radiation necrosis ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Despite complete surgical resection brain metastases are at significant risk of local recurrence without additional radiation therapy. Traditionally, the addition of postoperative whole brain radiotherapy (WBRT) has been considered the standard of care on the basis of randomized studies demonstrating its efficacy in reducing the risk of recurrence in the surgical bed as well as the incidence of new distant metastases. More recently, postoperative stereotactic radiosurgery (SRS) to the surgical bed has emerged as an effective and safe treatment option for resected brain metastases. Published randomized trials have demonstrated that postoperative SRS to the resection cavity provides superior local control compared to surgery alone, and significantly decreases the risk of neurocognitive decline compared to WBRT, without detrimental effects on survival. While studies support the use of postoperative SRS to the resection cavity as the standard of care after surgery, there are several issues that need to be investigated further with the aim of improving local control and reducing the risk of leptomeningeal disease and radiation necrosis, including the optimal dose prescription/fractionation, the timing of postoperative SRS treatment, and surgical cavity target delineation. We provide a clinical overview on current status and recent advances in resection cavity irradiation of brain metastases, focusing on relevant strategies that can improve local control and minimize the risk of radiation-induced toxicity.
- Published
- 2021
- Full Text
- View/download PDF
16. Deep learning-based automated segmentation of resection cavities on postsurgical epilepsy MRI
- Author
-
T. Campbell Arnold, Ramya Muthukrishnan, Akash R. Pattnaik, Nishant Sinha, Adam Gibson, Hannah Gonzalez, Sandhitsu R. Das, Brian Litt, Dario J. Englot, Victoria L. Morgan, Kathryn A. Davis, MD, and Joel M. Stein
- Subjects
Postoperative MRI ,Temporal lobe epilepsy ,Resection cavity ,Automated segmentation ,Convolutional neural network ,Hippocampal remnant ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Accurate segmentation of surgical resection sites is critical for clinical assessments and neuroimaging research applications, including resection extent determination, predictive modeling of surgery outcome, and masking image processing near resection sites. In this study, an automated resection cavity segmentation algorithm is developed for analyzing postoperative MRI of epilepsy patients and deployed in an easy-to-use graphical user interface (GUI) that estimates remnant brain volumes, including postsurgical hippocampal remnant tissue. This retrospective study included postoperative T1-weighted MRI from 62 temporal lobe epilepsy (TLE) patients who underwent resective surgery. The resection site was manually segmented and reviewed by a neuroradiologist (JMS). A majority vote ensemble algorithm was used to segment surgical resections, using 3 U-Net convolutional neural networks trained on axial, coronal, and sagittal slices, respectively. The algorithm was trained using 5-fold cross validation, with data partitioned into training (N = 27) testing (N = 9), and validation (N = 9) sets, and evaluated on a separate held-out test set (N = 17). Algorithm performance was assessed using Dice-Sørensen coefficient (DSC), Hausdorff distance, and volume estimates. Additionally, we deploy a fully-automated, GUI-based pipeline that compares resection segmentations with preoperative imaging and reports estimates of resected brain structures. The cross-validation and held-out test median DSCs were 0.84 ± 0.08 and 0.74 ± 0.22 (median ± interquartile range) respectively, which approach inter-rater reliability between radiologists (0.84–0.86) as reported in the literature. Median 95 % Hausdorff distances were 3.6 mm and 4.0 mm respectively, indicating high segmentation boundary confidence. Automated and manual resection volume estimates were highly correlated for both cross-validation (r = 0.94, p
- Published
- 2022
- Full Text
- View/download PDF
17. Oral Cavity: Anatomy and Histology
- Author
-
Brandwein-Weber, Margaret S. and Brandwein-Weber, Margaret S.
- Published
- 2018
- Full Text
- View/download PDF
18. Imaging the Intraoperative and Postoperative Brain
- Author
-
Ginat, Daniel Thomas, Schaefer, Pamela W., Moisi, Marc Daniel, Ginat, Daniel Thomas, editor, and Westesson, Per-Lennart A., editor
- Published
- 2017
- Full Text
- View/download PDF
19. Current status and recent advances in resection cavity irradiation of brain metastases.
- Author
-
Minniti, Giuseppe, Niyazi, Maximilian, Andratschke, Nicolaus, Guckenberger, Matthias, Palmer, Joshua D., Shih, Helen A., Lo, Simon S., Soltys, Scott, Russo, Ivana, Brown, Paul D., and Belka, Claus
- Subjects
- *
BRAIN metastasis , *STEREOTACTIC radiosurgery , *IRRADIATION , *SURGICAL excision , *RADIATION injuries , *RADIOTHERAPY - Abstract
Despite complete surgical resection brain metastases are at significant risk of local recurrence without additional radiation therapy. Traditionally, the addition of postoperative whole brain radiotherapy (WBRT) has been considered the standard of care on the basis of randomized studies demonstrating its efficacy in reducing the risk of recurrence in the surgical bed as well as the incidence of new distant metastases. More recently, postoperative stereotactic radiosurgery (SRS) to the surgical bed has emerged as an effective and safe treatment option for resected brain metastases. Published randomized trials have demonstrated that postoperative SRS to the resection cavity provides superior local control compared to surgery alone, and significantly decreases the risk of neurocognitive decline compared to WBRT, without detrimental effects on survival. While studies support the use of postoperative SRS to the resection cavity as the standard of care after surgery, there are several issues that need to be investigated further with the aim of improving local control and reducing the risk of leptomeningeal disease and radiation necrosis, including the optimal dose prescription/fractionation, the timing of postoperative SRS treatment, and surgical cavity target delineation. We provide a clinical overview on current status and recent advances in resection cavity irradiation of brain metastases, focusing on relevant strategies that can improve local control and minimize the risk of radiation-induced toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.
- Author
-
Hahnemann L, Krämer A, Fink C, Jungk C, Thomas M, Christopoulos P, Lischalk JW, Meis J, Hörner-Rieber J, Eichkorn T, Deng M, Lang K, Paul A, Meixner E, Weykamp F, Debus J, and König L
- Abstract
Background and Purpose: After surgical resection of brain metastases (BM), radiotherapy (RT) is indicated. Postoperative stereotactic radiosurgery (SRS) reduces the risk of local progression and neurocognitive decline compared to whole brain radiotherapy (WBRT). Aside from the optimal dose and fractionation, little is known about the combination of systemic therapy and postoperative fractionated stereotactic radiotherapy (fSRT), especially regarding tumour control and toxicity., Methods: In this study, 105 patients receiving postoperative fSRT with 35 Gy in 7 fractions performed with Cyberknife were retrospectively reviewed. Overall survival (OS), local control (LC) and total intracranial brain control (TIBC) were analysed via Kaplan-Meier method. Cox proportional hazards models were used to identify prognostic factors., Results: Median follow-up was 20.8 months. One-year TIBC was 61.6% and one-year LC was 98.6%. Median OS was 28.7 (95%-CI: 16.9-40.5) months. In total, local progression (median time not reached) occurred in 2.0% and in 20.4% radiation-induced contrast enhancements (RICE) of the cavity (after median of 14.3 months) were diagnosed. Absence of extracranial metastases was identified as an independent prognostic factor for superior OS (p = <0.001) in multivariate analyses, while a higher Karnofsky performance score (KPS) was predictive for longer OS in univariate analysis (p = 0.041). Leptomeningeal disease (LMD) developed in 13% of patients., Conclusion: FSRT after surgical resection of BM is an effective and safe treatment approach with excellent local control and acceptable toxicity. Further prospective randomized trials are needed to establish standardized therapeutic guidelines., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JHR received speaker fees from Pfizer Inc. and ViewRay Inc., travel reimbursement from ViewRay Inc., IntraOP Medical and Elekta Instrument AB as well as grants from IntraOP Medical and Varian Medical Systems outside the submitted work. J.D. received grants from View Ray Inc. J.D. received grants from CRI—The Clinical Research Institute GmbH, Accuray Incorporated, Accuray International Sàrl, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Merck Serono GmbH, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Pychlau GmbH, Nanobiotix A.A. and IntraOP Medical outside the submitted work. LK received speaker fees from Novocure outside the submitted work. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
21. Enhanced registration of ultrasound volumes by segmentation of resection cavity in neurosurgical procedures.
- Author
-
Canalini, Luca, Klein, Jan, Miller, Dorothea, and Kikinis, Ron
- Abstract
Purpose: Neurosurgeons can have a better understanding of surgical procedures by comparing ultrasound images obtained at different phases of the tumor resection. However, establishing a direct mapping between subsequent acquisitions is challenging due to the anatomical changes happening during surgery. We propose here a method to improve the registration of ultrasound volumes, by excluding the resection cavity from the registration process. Methods: The first step of our approach includes the automatic segmentation of the resection cavities in ultrasound volumes, acquired during and after resection. We used a convolution neural network inspired by the 3D U-Net. Then, subsequent ultrasound volumes are registered by excluding the contribution of resection cavity. Results: Regarding the segmentation of the resection cavity, the proposed method achieved a mean DICE index of 0.84 on 27 volumes. Concerning the registration of the subsequent ultrasound acquisitions, we reduced the mTRE of the volumes acquired before and during resection from 3.49 to 1.22 mm. For the set of volumes acquired before and after removal, the mTRE improved from 3.55 to 1.21 mm. Conclusions: We proposed an innovative registration algorithm to compensate the brain shift affecting ultrasound volumes obtained at subsequent phases of neurosurgical procedures. To the best of our knowledge, our method is the first to exclude automatically segmented resection cavities in the registration of ultrasound volumes in neurosurgery. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
- Author
-
Rami A. El Shafie, Thorsten Dresel, Dorothea Weber, Daniela Schmitt, Kristin Lang, Laila König, Simon Höne, Tobias Forster, Bastian von Nettelbladt, Tanja Eichkorn, Sebastian Adeberg, Jürgen Debus, Stefan Rieken, and Denise Bernhardt
- Subjects
resection cavity ,radiosurgery ,palliative ,radiotherapy ,whole-brain radiotherapy ,stereotactic ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Introduction: Following the resection of brain metastases (BM), whole-brain radiotherapy (WBRT) is a long-established standard of care. Its position was recently challenged by the less toxic single-session radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT) of the resection cavity, reducing dose exposure of the healthy brain.Patients and Methods: We analyzed 101 patients treated with either SRS/FSRT (n = 50) or WBRT (n = 51) following BM resection over a 5-year period. Propensity score adjustment was done for age, total number of BM, timepoint of BM diagnosis, controlled primary and extracranial metastases. A Cox Proportional Hazards model with univariate and multivariate analysis was fitted for overall survival (OS), local control (LC) and distant brain control (DBC).Results: Median patient age was 61 (interquartile range, IQR: 56–67) years and the most common histology was non-small cell lung cancer, followed by breast cancer. 38% of the patients had additional unresected BM. Twenty-four patients received SRS, 26 patients received FSRT and 51 patients received WBRT. Median OS in the SRS/FSRT subgroup was not reached (IQR NA−16.7 months) vs. 12.6 months (IQR 21.3–4.4) in the WBRT subgroup (hazard ratio, HR 3.3, 95%-CI: [1.5; 7.2] p < 0.002). Twelve-months LC-probability was 94.9% (95%-CI: [88.3; 100.0]) in the SRS subgroup vs. 81.7% (95%-CI: [66.6; 100.0]) in the WBRT subgroup (HR 0.2, 95%-CI: [0.01; 0.9] p = 0.037). Twelve-months DBC-probabilities were 65.0% (95%-CI: [50.8; 83.0]) and 58.8% (95%-CI: [42.9; 80.7]), respectively (HR 1.4, 95%-CI: [0.7; 2.7] p = 0.401). In propensity score-adjusted multivariate analysis, incomplete resection negatively impacted OS (HR 3.9, 95%-CI: [2.0;7.4], p < 0.001) and LC (HR 5.4, 95%-CI: [1.3; 21.9], p = 0.018). Excellent clinical performance (HR 0.4, 95%-CI: [0.2; 0.9], p = 0.030) and better graded prognostic assessment (GPA) score (HR 0.4, 95%-CI: [0.2; 1.0], p = 0.040) were prognostic of superior OS. A higher number of BM was associated with a greater risk of developing new distant BM (HR 5.6, 95%-CI: [1.0; 30.4], p = 0.048). In subgroup analysis, larger cavity volume (HR 1.1, 95%-CI: [1.0; 1.3], p = 0.033) and incomplete resection (HR 12.0, 95%-CI: [1.2; 118.3], p = 0.033) were associated with inferior LC following SRS/FSRT.Conclusion: This is the first propensity score-adjusted direct comparison of SRS/FSRT and WBRT following the resection of BM. Patients receiving SRS/FSRT showed longer OS and LC compared to WBRT. Future analyses will address the optimal choice of safety margin, dose and fractionation for postoperative stereotactic RT of the resection cavity.
- Published
- 2020
- Full Text
- View/download PDF
23. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns.
- Author
-
El Shafie, Rami A., Dresel, Thorsten, Weber, Dorothea, Schmitt, Daniela, Lang, Kristin, König, Laila, Höne, Simon, Forster, Tobias, von Nettelbladt, Bastian, Eichkorn, Tanja, Adeberg, Sebastian, Debus, Jürgen, Rieken, Stefan, and Bernhardt, Denise
- Subjects
STEREOTACTIC radiosurgery ,BRAIN metastasis ,NON-small-cell lung carcinoma ,PROPORTIONAL hazards models ,STEREOTACTIC radiotherapy ,BRAINWASHING - Abstract
Introduction: Following the resection of brain metastases (BM), whole-brain radiotherapy (WBRT) is a long-established standard of care. Its position was recently challenged by the less toxic single-session radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT) of the resection cavity, reducing dose exposure of the healthy brain. Patients and Methods: We analyzed 101 patients treated with either SRS/FSRT (n = 50) or WBRT (n = 51) following BM resection over a 5-year period. Propensity score adjustment was done for age, total number of BM, timepoint of BM diagnosis, controlled primary and extracranial metastases. A Cox Proportional Hazards model with univariate and multivariate analysis was fitted for overall survival (OS), local control (LC) and distant brain control (DBC). Results: Median patient age was 61 (interquartile range, IQR: 56–67) years and the most common histology was non-small cell lung cancer, followed by breast cancer. 38% of the patients had additional unresected BM. Twenty-four patients received SRS, 26 patients received FSRT and 51 patients received WBRT. Median OS in the SRS/FSRT subgroup was not reached (IQR NA−16.7 months) vs. 12.6 months (IQR 21.3–4.4) in the WBRT subgroup (hazard ratio, HR 3.3, 95%-CI: [1.5; 7.2] p < 0.002). Twelve-months LC-probability was 94.9% (95%-CI: [88.3; 100.0]) in the SRS subgroup vs. 81.7% (95%-CI: [66.6; 100.0]) in the WBRT subgroup (HR 0.2, 95%-CI: [0.01; 0.9] p = 0.037). Twelve-months DBC-probabilities were 65.0% (95%-CI: [50.8; 83.0]) and 58.8% (95%-CI: [42.9; 80.7]), respectively (HR 1.4, 95%-CI: [0.7; 2.7] p = 0.401). In propensity score-adjusted multivariate analysis, incomplete resection negatively impacted OS (HR 3.9, 95%-CI: [2.0;7.4], p < 0.001) and LC (HR 5.4, 95%-CI: [1.3; 21.9], p = 0.018). Excellent clinical performance (HR 0.4, 95%-CI: [0.2; 0.9], p = 0.030) and better graded prognostic assessment (GPA) score (HR 0.4, 95%-CI: [0.2; 1.0], p = 0.040) were prognostic of superior OS. A higher number of BM was associated with a greater risk of developing new distant BM (HR 5.6, 95%-CI: [1.0; 30.4], p = 0.048). In subgroup analysis, larger cavity volume (HR 1.1, 95%-CI: [1.0; 1.3], p = 0.033) and incomplete resection (HR 12.0, 95%-CI: [1.2; 118.3], p = 0.033) were associated with inferior LC following SRS/FSRT. Conclusion: This is the first propensity score-adjusted direct comparison of SRS/FSRT and WBRT following the resection of BM. Patients receiving SRS/FSRT showed longer OS and LC compared to WBRT. Future analyses will address the optimal choice of safety margin, dose and fractionation for postoperative stereotactic RT of the resection cavity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Multimodal Imaging in Glioma Surgery
- Author
-
Šteňo, Andrej, Giussani, Carlo, Riva, Matteo, Prada, Francesco, editor, Solbiati, Luigi, editor, Martegani, Alberto, editor, and DiMeco, Francesco, editor
- Published
- 2016
- Full Text
- View/download PDF
25. Intraoperative Findings in Brain Tumor Surgery
- Author
-
Coburger, Jan, König, Ralph W., Prada, Francesco, editor, Solbiati, Luigi, editor, Martegani, Alberto, editor, and DiMeco, Francesco, editor
- Published
- 2016
- Full Text
- View/download PDF
26. Intraoperative MRI
- Author
-
Buchfelder, Michael, Schlaffer, Sven-Martin, Bonneville, Jean-François, Bonneville, Fabrice, Cattin, Françoise, and Nagi, Sonia
- Published
- 2016
- Full Text
- View/download PDF
27. Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI–Linear Accelerator
- Author
-
Beatriz Guevara, Kaylie Cullison, Danilo Maziero, Gregory A. Azzam, Macarena I. De La Fuente, Karen Brown, Alessandro Valderrama, Jessica Meshman, Adrian Breto, John Chetley Ford, and Eric A. Mellon
- Subjects
Cancer Research ,Oncology ,dose reduction ,glioblastoma ,resection cavity ,hippocampi ,radiotherapy ,cognitive function - Abstract
During radiation therapy (RT) of glioblastoma, daily MRI with combination MRI–linear accelerator (MRI–Linac) systems has demonstrated significant anatomic changes, including evolving post-surgical cavity shrinkage. Cognitive function RT for brain tumors is correlated with radiation doses to healthy brain structures, especially the hippocampi. Therefore, this study investigates whether adaptive planning to the shrinking target could reduce normal brain RT dose with the goal of improving post-RT function. We evaluated 10 glioblastoma patients previously treated on a 0.35T MRI–Linac with a prescription of 60 Gy delivered in 30 fractions over six weeks without adaptation (“static plan”) with concurrent temozolomide chemotherapy. Six weekly plans were created per patient. Reductions in the radiation dose to uninvolved hippocampi (maximum and mean) and brain (mean) were observed for weekly adaptive plans. The dose (Gy) to the hippocampi for static vs. weekly adaptive plans were, respectively: max 21 ± 13.7 vs. 15.2 ± 8.2 (p = 0.003) and mean 12.5 ± 6.7 vs. 8.4 ± 4.0 (p = 0.036). The mean brain dose was 20.6 ± 6.0 for static planning vs. 18.7 ± 6.8 for weekly adaptive planning (p = 0.005). Weekly adaptive re-planning has the potential to spare the brain and hippocampi from high-dose radiation, possibly reducing the neurocognitive side effects of RT for eligible patients.
- Published
- 2023
- Full Text
- View/download PDF
28. Intraoperative Ultrasonography in Tumor Surgery
- Author
-
Miller, Dorothea, Hayat, M. A., Series editor, and Hayat, M.A., editor
- Published
- 2014
- Full Text
- View/download PDF
29. Simulation of Ultrasound Images for Validation of MR to Ultrasound Registration in Neurosurgery
- Author
-
Rivaz, Hassan, Collins, D. Louis, Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Kobsa, Alfred, Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Nierstrasz, Oscar, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Weikum, Gerhard, Series editor, Linte, Cristian A., editor, Yaniv, Ziv, editor, Fallavollita, Pascal, editor, Abolmaesumi, Purang, editor, and Holmes, David R., III, editor
- Published
- 2014
- Full Text
- View/download PDF
30. Radiopeptide Therapy of Brain Tumors
- Author
-
Forrer, Flavio, Cordier, Dominik, Brady, Luther W., Series editor, Lu, Jiade J., Series editor, Nieder, Carsten, Series editor, and Baum, Richard P., editor
- Published
- 2014
- Full Text
- View/download PDF
31. MR Imaging Evaluation of Posttreatment Changes in Brain Neoplasms
- Author
-
da Cruz, L. Celso Hygino, Jr, Batista, Raquel Ribeiro, de Carvalho Rangel, Claudio, Luna, Antonio, editor, Vilanova, Joan C., editor, Hygino Da Cruz Jr., L. Celso, editor, and Rossi, Santiago E., editor
- Published
- 2014
- Full Text
- View/download PDF
32. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
- Author
-
Minniti, Giuseppe, Scaringi, Claudia, Lanzetta, Gaetano, Anzellini, Dimitri, Bianciardi, Federico, Tolu, Barbara, Morace, Roberta, Romano, Andrea, Osti, Mattia, Gentile, PierCarlo, and Paolini, Sergio
- Subjects
- *
STEREOTACTIC radiosurgery , *NON-small-cell lung carcinoma , *BRAIN metastasis , *MENINGEAL cancer , *THERAPEUTICS , *SURGICAL excision - Abstract
• Postoperative SRS is usually recommended for resected brain metastases. • 3 x 9 Gy demonstrates activity in both intact and resected large NSCLC metastases. • Local control is comparable between resected and intact large brain metastases. • A worse safety profile can be expected after surgery and postoperative SRS (3 x 9 Gy). Purpose: to investigate clinical outcomes in patients with large brain metastases from non-small-cell lung cancer (NSCLC) who received surgical resection and postoperative stereotactic radiosurgery or SRS alone. Patients and Methods: Two hundred and twenty-two patients with 241 large brain metastases (2–4 cm in size) who received surgery and multi-fraction SRS (mfSRS) to the resection cavity or mfSRS alone were analyzed. For all lesions the delivered dose was 3 x 9 Gy over three consecutive days. Primary endpoint of the study was local control (LC). Secondary endpoints included early improvement of neurological deficits, changes in performance status, treatment-related toxicity, radiation-induced brain necrosis (RN), distant brain failure (DBF), and overall survival (OS). Kaplan-Meier analysis and cumulative incidence function were used for comparing the probability of failure. Results: At a median follow-up of 13 months, median OS times and 1-year survival rates were comparable: 13.5 months and 59% for patients receiving surgery and postoperative mfSRS to the resection cavity and 15.2 months and 68% for those treated with mfSRS alone (p = 0.2). Median DBF did not differ significantly between groups (surgery and mfSRS,12 months; mfSRS,14 months). Eighteen patients receiving surgery and mfSRS and 17 patients treated with mfSRS alone recurred locally (p = 0.2); respective 6-month and 12-month LC rates were 87% and 83% and 96% and 91% (p = 0.15). The 1-year cumulative incidence rates of RN were 15% and 7% after postoperative mfSRS and mfSRS alone (p = 0.03), respectively. Conclusions: In conclusion, mfSRS is an effective treatment for patients with large brain metastases from NSCLC resulting in equivalent LC and lower RN and risk of leptomeningeal spread compared to surgery and mf-SRS to the resection cavity. Surgery is an effective treatment option for patients with large symptomatic brain metastases who require rapid relief of neurological symptoms caused by tumor mass effect. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
33. Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines.
- Author
-
McDermott, David M., Hack, Joshua D., Cifarelli, Christoper P., and Vargo, John A.
- Abstract
Background: Significant heterogeneity exists in target volumes for postoperative stereotactic radiosurgery (SRS) for brain metastases. A set of contouring guidelines was recently published, and we investigated the impact of deviations. Methods: Patients (n = 41) undergoing single-fraction Gamma Knife SRS following surgical resection of brain metastases from 2011 to 2017 were retrospectively reviewed. SRS included the entire contrast-enhancing cavity with heterogeneity in inclusion of the surgical tract and no routine margin along the dura or clinical target volume margin. Follow-up MR imaging was fused with SRS plans to assess patterns of failure. Results: The median follow-up was 11.1 months with a median prescription of 18 Gy. There were 5 local failures: infield (n = 3, 60%), surgical tract (n = 1, 20%), and marginal > 5 mm from the resection cavity (n = 1, 20%). No marginal failures < 5 mm or dural margin failures were noted. For deep lesions (n = 13), 62% (n = 8) had the entire tract covered. The only tract recurrence was in a deep lesion without coverage of the surgical tract (n = 1/5). Conclusion: In this small preliminary experience, despite no routine inclusion of the dural tract or bone flap, no failures were noted in these locations. Omission of the surgical tract in deep lesions may increase failure rates. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
- Author
-
Vargo, John A., Sparks, Kristie M., Singh, Rahul, Jacobson, Geraldine M., Hack, Joshua D., and Cifarelli, Christopher P.
- Abstract
Background and purpose: Post-operative SRS (stereotactic radiosurgery) for large brain metastases is challenged by risks of radiation necrosis that limit SRS dose. Intraoperative radiotherapy (IORT) is a potential alternative, however standard dose recommendations are lacking.Methods and materials: Twenty consecutive brain metastases treated with post-operative SRS were retrospectively compared to IORT plans generated for 10-30 Gy in 1 fraction to 0-5 mm by estimating the applicator size and distance from critical organs using pre-operative and post-operative MRI. Additionally, 7 consecutive patients treated with IORT 30 Gy to surface were compared to retrospectively generated SRS plans using the post-operative MRI to 15-20 Gy and 30 Gy in 1 fraction marginal dose.Results: For the 20 resection cavities treated with SRS and retrospectively compared to IORT, IORT from 10 to 30Gy resulted in lower or not significantly different doses to the optic apparatus and brainstem. Comparatively for the 7 patients treated with IORT 30 Gy to retrospective SRS plans to standard 15-20 Gy and 30 Gy marginal dose, IORT resulted in significantly lower doses to the optic apparatus and brainstem. At a median follow-up of 6.2 months, 86% of patients treated with surgery and IORT achieved local control and 0% developed radiographic or symptomatic radiation necrosis.Conclusions: Critical organ dosimetry for IORT remains generally lower than that achieved with single fraction SRS following resection of large brain metastases. We recommend 30 Gy to surface as the preferred prescription, consistent with the dose recommendation for IORT in glioblastoma used in the ongoing INTRAGO-II phase-III trial. Early clinical outcomes appear promising for surgery and IORT. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
35. Intracranial Photodynamic Therapy
- Author
-
Wilson, Brian C., Madsen, Steen J., and Madsen, Steen J., editor
- Published
- 2013
- Full Text
- View/download PDF
36. Commentary
- Author
-
Hackert, Thilo, Büchler, Markus W., Mantke, René, editor, Lippert, Hans, editor, Büchler, Markus W., editor, and Sarr, Michael G., editor
- Published
- 2013
- Full Text
- View/download PDF
37. Pediatric Brain Tumor Biopsy or Resection: Use of Postoperative Nonnarcotic Analgesic Medication
- Author
-
Tubbs, R. Shane, Mortazavi, Martin M., Cohen-Gadol, Aaron A., and Hayat, M.A., editor
- Published
- 2012
- Full Text
- View/download PDF
38. Predicting the Location of Glioma Recurrence after a Resection Surgery
- Author
-
Stretton, Erin, Mandonnet, Emmanuel, Geremia, Ezequiel, Menze, Bjoern H., Delingette, Hervé, Ayache, Nicholas, Hutchison, David, editor, Kanade, Takeo, editor, Kittler, Josef, editor, Kleinberg, Jon M., editor, Mattern, Friedemann, editor, Mitchell, John C., editor, Naor, Moni, editor, Nierstrasz, Oscar, editor, Pandu Rangan, C., editor, Steffen, Bernhard, editor, Sudan, Madhu, editor, Terzopoulos, Demetri, editor, Tygar, Doug, editor, Vardi, Moshe Y., editor, Weikum, Gerhard, editor, Durrleman, Stanley, editor, Fletcher, Tom, editor, Gerig, Guido, editor, and Niethammer, Marc, editor
- Published
- 2012
- Full Text
- View/download PDF
39. Imaging the Postoperative Brain
- Author
-
Ginat, Daniel Thomas, Schaefer, Pamela W., Ginat, Daniel Thomas, and Westesson, Per-Lennart A.
- Published
- 2012
- Full Text
- View/download PDF
40. Brain Tumor Resection: Intra-operative Ultrasound Imaging
- Author
-
Renner, Christof and Hayat, M. A., editor
- Published
- 2011
- Full Text
- View/download PDF
41. Robust Skull Stripping of Clinical Glioblastoma Multiforme Data
- Author
-
Speier, William, Iglesias, Juan E., El-Kara, Leila, Tu, Zhuowen, Arnold, Corey, Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Nierstrasz, Oscar, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Sudan, Madhu, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Vardi, Moshe Y., Series editor, Weikum, Gerhard, Series editor, Fichtinger, Gabor, editor, Martel, Anne, editor, and Peters, Terry, editor
- Published
- 2011
- Full Text
- View/download PDF
42. Preoperative Visualization of the Lenticulostriate Arteries Associated with Insulo-Opercular Gliomas Using 3-T Magnetic Resonance Imaging
- Author
-
Kumabe, Toshihiro, Saito, Ryuta, Kanamori, Masayuki, Sonoda, Yukihiko, Higano, Shuichi, Takahashi, Shoki, Tominaga, Teiji, and Takahashi, Shoki, editor
- Published
- 2011
- Full Text
- View/download PDF
43. Ischemic Complications Associated with Resection of Opercular Gliomas
- Author
-
Kumabe, Toshihiro, Kanamori, Masayuki, Saito, Ryuta, Nagamatsu, Ken-ichi, Sonoda, Yukihiko, Higano, Shuichi, Takahashi, Shoki, Tominaga, Teiji, and Takahashi, Shoki, editor
- Published
- 2011
- Full Text
- View/download PDF
44. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
- Author
-
Bilger, Angelika, Bretzinger, Eva, Fennell, Jamina, Nieder, Carsten, Lorenz, Hannah, Oehlke, Oliver, Grosu, Anca‐ligia, Specht, Hanno M., and Combs, Stephanie E.
- Subjects
- *
STEREOTACTIC radiotherapy , *BRAIN metastasis , *SALVAGE therapy , *PHYSIOLOGICAL effects of radiation , *QUALITY of life , *THERAPEUTICS - Abstract
Abstract: In patients undergoing surgical resection of brain metastases, the risk of local recurrence remains high. Adjuvant whole brain radiation therapy (WBRT) can reduce the risk of local relapse but fails to improve overall survival. At two tertiary care centers in Germany, a retrospective study was performed to evaluate the role of hypofractionated stereotactic radiotherapy (HFSRT) in patients with brain metastases after surgical resection. In particular, need for salvage treatment, for example, WBRT, surgery, or stereotactic radiosurgery (SRS), was evaluated. Both intracranial local (LF) and locoregional (LRF) failures were analyzed. A total of 181 patients were treated with HFSRT of the surgical cavity. In addition to the assessment of local control and distant intracranial control, we analyzed treatment modalities for tumor recurrence including surgical strategies and reirradiation. Imaging follow‐up for the evaluation of LF and LRF was available in 159 of 181 (88%) patients. A total of 100 of 159 (63%) patients showed intracranial progression after HFSRT. A total of 81 of 100 (81%) patients received salvage therapy. Fourteen of 81 patients underwent repeat surgery, and 78 of 81 patients received radiotherapy as a salvage treatment (53% WBRT). Patients with single or few metastases distant from the initial site or with WBRT in the past were retreated by HFSRT (14%) or SRS, 33%. Some patients developed up to four metachronous recurrences, which could be salvaged successfully. Eight (4%) patients experienced radionecrosis. No other severe side effects (CTCAE≥3) were observed. Postoperative HFSRT to the resection cavity resulted in a crude rate for local control of 80.5%. Salvage therapy for intracranial progression was commonly needed, typically at distant sites. Salvage therapy was performed with WBRT, SRS, and surgery or repeated HFSRT of the resection cavity depending on the tumor spread and underlying histology. Prospective studies are warranted to clarify whether or not the sequence of these therapies is important in terms of quality of life, risk of radiation necrosis, and likelihood of neurological cause of death. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
45. Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases.
- Author
-
Combs, Stephanie E., Bilger, Angelika, Diehl, Christian, Bretzinger, Eva, Lorenz, Hannah, Oehlke, Oliver, Specht, Hanno M., Kirstein, Anna, and Grosu, Anca‐ligia
- Subjects
- *
BRAIN metastasis , *RADIOTHERAPY , *ADJUVANT treatment of cancer , *STEREOTACTIC radiotherapy , *PROGNOSIS , *PATIENTS - Abstract
Abstract: Brain metastases show a recurrence rate of about 50% after surgical resection. Adjuvant radiotherapy can prevent progression; however, whole‐brain radiotherapy (WBRT) can be associated with significant side effects. Local hypofractionated stereotactic radiotherapy (HFSRT) is a good alternative to provide local control with minimal toxicity. In this multicenter analysis, we evaluated the treatment outcome of local HFSRT after resection brain metastases in 181 patients. Patient's characteristics, treatment data as well as follow‐up data were collected and analyzed with special focus on local control, locoregional control and survival. After a median follow‐up of 12.6 months (range 0.3–80.2 months), the crude rate for local control was 80.5%; 1‐ and 2‐year local recurrence‐free survival rates were 75% and 70% (median not reached). Resection cavity size was a significant predictor for local recurrence (P = 0.033). The median overall survival was 16.0 months. Both graded prognostic assessment score and recursive partitioning analysis were accurate predictors of survival. HFSRT leads to excellent local control and has a high potential to consolidate results after surgery; acute and late toxicity is low. Distant intracerebral metastases occur frequently during follow‐up, and therefore, a close patient monitoring needs to be warranted if whole‐brain radiotherapy is omitted. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
46. APBI 3D Conformal External Beam: The MGH Technique
- Author
-
MacDonald, Shannon M., Gierga, David P., Napolitano, Brian, Taghian, Alphonse G., Wazer, David E., editor, Arthur, Douglas W., editor, and Vicini, Frank A., editor
- Published
- 2009
- Full Text
- View/download PDF
47. Comment on Clinical Trial NCT00950001 and NCCTG/N107C/CEC.3: Are We Treating Cancer or Water?
- Author
-
Junfang Gao
- Subjects
medicine.medical_specialty ,business.industry ,Residual cancer ,medicine.medical_treatment ,Rate control ,Cancer ,medicine.disease ,Radiosurgery ,Clinical trial ,medicine ,Resection Cavity ,Radiology ,business ,Survival rate - Abstract
During the implementation of clinical trials NCT00950001 and NCCTG/N107C/CEC.3 on post-operative stereotactic radiosurgery into clinic, it brought us some thinking of fundamental concept in science that the local control rate and survival rate rely on the treatment of marginal region more than resection cavity. Marginal region might still contain residual cancer cell while the resection cavity contains only water fluid most time. Radiation treatment should focus more on the margin rather than the cavity, thus treating cancer rather than water.
- Published
- 2021
48. Multifunctional hybrid sponge for in situ postoperative management to inhibit tumor recurrence
- Author
-
Haixia Wang, Shixian Lv, Yanyan Chen, Yuanyuan Jin, Yu Tao, Mingqiang Li, and Yun Luo
- Subjects
biology ,business.industry ,Biomedical Engineering ,Tumor cells ,biology.organism_classification ,Tumor site ,Resection ,Postoperative management ,Tumor recurrence ,Sponge ,Cancer research ,Medicine ,General Materials Science ,Resection Cavity ,Electrospun fiber ,business - Abstract
Disseminated tumor cells in bleeding and residual tumor cells in the resection tumor site are the primary factors that result in tumor recurrence after surgery. Safe and efficient local implantation of the drug depot system into the resection cavity to inhibit tumor recurrence would be of great benefit to reduce the mortality of postoperative patients. Here, a sandwich-like doxorubicin-triptolide-loaded fiber/(chitosan/gelatin) sponge, DTF/CGS, is fabricated, combining hemostatic, antibacterial, and chemotherapeutic capability. The CGS obtained via freeze-drying can efficiently prevent bleeding; meanwhile, the metastatic residual tumor cells are stuck with the clotted absorbed blood. Subsequently, dual drugs released from the electrospun fiber can further kill the stuck tumor cells in CGS and the disseminated tumor cells to significantly inhibit the tumor recurrence. This antitumor recurrence strategy by immediately implanting a multifunctional hybrid sponge for in situ postoperative management may possess great potential for preventing tumor recurrence.
- Published
- 2021
49. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
- Author
-
Minniti, Giuseppe, Paolini, Sergio, D'Andrea, Giancarlo, Lanzetta, Gaetano, Cicone, Francesco, Confaloni, Veronica, Bozzao, Alessandro, Esposito, Vincenzo, and Osti, Mattia
- Abstract
To investigate local control and radiation-induced brain necrosis in patients with melanoma brain metastases who received complete resection plus fractionated stereotactic radiosurgery (fSRS, 3 × 9 Gy) or fSRS alone. Factors associated with the clinical outcomes and the development of brain necrosis have been assessed. One hundred and twenty consecutive patients with 137 melanoma brain metastases who received surgery plus fSRS (S + fSRS) or fSRS alone were analyzed. All lesions evaluated in the study were treated with a dose of 27 Gy given in 3 fractions over three consecutive days. Cumulative incidence analysis was used to compare local failure (LF), distant brain failure (DBF), and radiation-induced brain necrosis (RN) between groups from the time of SRS. At a median follow-up of 13 months, median OS times and 1-year survival rates were comparable: S + fSRS, 14 months and 85%; fSRS, 12 months and 85% ( p = 0.2). Median DBF did not differ significantly by group, being 14 months for both groups. Nine patients who received S + fSRS and 20 patients treated with fSRS recurred locally ( p = 0.03). Six-month and 1-year LF rates were 5 and 12% in S + fSRS group and 17 and 28% in fSRS group ( p = 0.02). RN occurred in 21 patients (S + fSRS, n = 14; fSRS, n = 7; p = 0.1). The cumulative 1-year incidence of RN was 13% after S + fSRS and 8% after fSRS ( p = 0.15). In conclusion, postoperative SRS (3 × 9 Gy) to the resection cavity is an effective treatment modality for melanoma brain metastases associated with better local control as compared with fSRS alone. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
50. Local Integration of Commercially Available Intra-operative MR-scanner and Neurosurgical Guidance for Metalloporphyrin-Guided Tumor Resection and Photodynamic Therapy
- Author
-
Dean, David, Duerk, Jeffrey, Wendt, Michael, Metzger, Andrew, Lilge, Lothar, Wilson, Brian, Yang, Victor, Selman, Warren, Lewin, Jonathan, Ratcheson, Robert, Goos, Gerhard, editor, Hartmanis, Juris, editor, van Leeuwen, Jan, editor, Delp, Scott L., editor, DiGoia, Anthony M., editor, and Jaramaz, Branislav, editor
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.